Skip to main content

Advertisement

Table 3 JUNB expression in primary and metastatic tumors

From: The prognostic value of JUNB-positive CTCs in metastatic breast cancer: from bioinformatics to phenotypic characterization

Patient Material JUN B IHC EVAL - FFPE tissues JUNB positive (+) CTCs
% (0–100) Intensity (0–3) H-score* (0–300)
1 Primary tumor 0 0 0
2 Primary tumor 0 0 0 +
3 Primary tumor 3 2 6 +
4 Primary tumor 5 1 5 Negative for CTCs
5 Primary tumor 0 0 0 Negative for CTCs
6 Primary tumor 0 0 0 Negative for CTCs
7 Primary tumor 0 0 0 Negative for CTCs
8 Primary tumor 9 1 9
9 Primary tumor 0 0 0 Negative for CTCs
10 Primary tumor 0 0 0 Negative for CTCs
11 Primary tumor 0 0 0 +
Metastasis 40 3 120
12 Metastasis 10 2 20 Negative for CTCs
13 Metastasis 35 3 105 +
14 Metastasis 40 &20 2&3 140 +
  1. *Histoscore (H-score) was calculated by a semi-quantitative assessment of both the intensity of staining (graded as: 0: no-staining; 1: weak; 2: medium; or 3: strong) and the percentage of positive cells. The percentage of cells at each staining intensity level was calculated, and an H-score was assigned summming the individual H-scores for each intensity level using the following formula: [1 × (% cells 1+) + 2 × (% cells 2+) + 3 × (% cells 3+)]. The range of possible scores was from 0 to 300